BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35105810)

  • 1. Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.
    Erickson JR; Stevens-Ayers T; Mair F; Edmison B; Boeckh M; Bradley P; Prlic M
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.
    Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M; Khoury HJ; Grizzle A; Cheeseman JA; Conger JA; Robertson J; Garrett A; Kirk AD; Waller EK; Blazar BR; Mehta AK; Robins HS; Kean LS
    Blood; 2015 Jun; 125(25):3835-50. PubMed ID: 25852054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.
    Yeh AC; Varelias A; Reddy A; Barone SM; Olver SD; Chilson K; Onstad LE; Ensbey KS; Henden AS; Samson L; Jaeger CA; Bi T; Dahlman KB; Kim TK; Zhang P; Degli-Esposti MA; Newell EW; Jagasia MH; Irish JM; Lee SJ; Hill GR
    Blood; 2021 Dec; 138(26):2874-2885. PubMed ID: 34115118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.
    Zhou W; Longmate J; Lacey SF; Palmer JM; Gallez-Hawkins G; Thao L; Spielberger R; Nakamura R; Forman SJ; Zaia JA; Diamond DJ
    Blood; 2009 Jun; 113(25):6465-76. PubMed ID: 19369230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
    Krawczyk A; Ackermann J; Goitowski B; Trenschel R; Ditschkowski M; Timm J; Ottinger H; Beelen DW; Grüner N; Fiedler M
    J Clin Virol; 2018; 99-100():61-66. PubMed ID: 29331844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.
    Gandhi MK; Wills MR; Okecha G; Day EK; Hicks R; Marcus RE; Sissons JG; Carmichael AJ
    Blood; 2003 Nov; 102(9):3427-38. PubMed ID: 12869514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
    Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
    Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
    Terasako-Saito K; Nakasone H; Tanaka Y; Yamazaki R; Sato M; Sakamoto K; Ishihara Y; Kawamura K; Akahoshi Y; Hayakawa J; Wada H; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2014 Dec; 16(6):930-40. PubMed ID: 25430567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
    Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
    J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.
    van der Heiden PLJ; van Egmond HM; Veld SAJ; van de Meent M; Eefting M; de Wreede LC; Halkes CJM; Falkenburg JHF; Marijt WAF; Jedema I
    Transpl Immunol; 2018 Aug; 49():54-58. PubMed ID: 29679650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation.
    Camargo JF; Wieder ED; Kimble E; Benjamin CL; Kolonias DS; Kwon D; Chen XS; Komanduri KV
    Blood; 2019 Feb; 133(8):867-877. PubMed ID: 30573634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors.
    Hoegh-Petersen M; Roa L; Liu Y; Zhou F; Ugarte-Torres A; Louie P; Fonseca K; Khan F; Russell JA; Storek J
    Cytotherapy; 2012 Feb; 14(2):194-204. PubMed ID: 22149135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
    Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J
    Front Immunol; 2018; 9():389. PubMed ID: 29545802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients.
    Shams El-Din AA; El-Desoukey NA; Amin Tawadrous DG; Fouad NMBE; Abdel-Mooti M; Hotar SF
    Hematology; 2018 Sep; 23(8):463-469. PubMed ID: 29313439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation.
    Liu J; Chang YJ; Yan CH; Xu LP; Jiang ZF; Zhang XH; Liu KY; Huang XJ
    J Infect; 2016 Sep; 73(3):261-70. PubMed ID: 27311748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.